(Q35540392)

8 August 2017

1 reference

title

Hypertension, hypertension-clustering factors and Alzheimer's disease (English)

1 reference

8 August 2017

main subject

arterial hypertension

0 references

1 reference

https://api.crossref.org/works/10.1179/016164103101201986

12 March 2024

author name string

Ingmar Skoog

series ordinal

1

1 reference

8 August 2017

Deborah Gustafson

series ordinal

2

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14503023

12 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1179/016164103101201986

1 reference

https://api.crossref.org/works/10.1179/016164103101201986

12 March 2024

published in

Neurological Research

1 reference

8 August 2017

volume

25

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

675-680

1 reference

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Relationship between blood pressure and Alzheimer's disease in Linxian County, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Low blood pressure and dementia in elderly people: the Kungsholmen project

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

A population-based study on blood pressure and brain atrophy in 85-year-olds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Blood pressure regulation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

The effects of systemic hypotension upon the human brain. Clinical and neuropathological observations in 11 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Silent brain infarcts and the risk of dementia and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

The prevalence of white-matter lesions on computed tomography of the brain in demented and nondemented 85-year-olds

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

A population-based study of dementia in 85-year-olds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

An 18-year follow-up of overweight and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Demonstrating the case that AD is a vascular disease: epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Brain angiotensin receptor subtypes in the control of physiological and behavioral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Hypertension and cerebral white matter lesions in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Incidence of hypertension in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Risk stratification in hypertension: new insights from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

15-year longitudinal study of blood pressure and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

A follow-up study of blood pressure and cerebral white matter lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

The effects of additional pathology on the cognitive deficit in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Apoptosis in target organs of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Childhood traumas and psychosocial characteristics of 50-year-old men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Less nitric oxide, more pressure, or the converse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101201986

21 January 2018

Neurobiology of Aging

5

21

49

Lau nerli

2000

1 reference

https://api.crossref.org/works/10.1179/016164103101201986

Proceedings of the National Academy of Sciences of the United States of America

12 March 2024

60

10

10

Fassbender K

2001

1 reference

https://api.crossref.org/works/10.1179/016164103101201986

Clinical neuroscience (New York, N.Y.)

12 March 2024

67

4

322

Mooradian AD

1997

1 reference

https://api.crossref.org/works/10.1179/016164103101201986

12 March 2024

Identifiers

1 reference

8 August 2017

1 reference